+987.9%
MRNA vs VFC
+52.5%
+935.5%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | VFC | Excess | Alpha |
|---|---|---|---|---|
| 1D | +13.1% | +4.4% | +8.7% | +11.3% |
| 7D | +20.6% | +21.5% | -0.8% | +12.0% |
| 30D | +27.1% | +46.7% | -19.5% | +9.4% |
| 3M | +353.4% | +38.4% | +315.0% | +297.9% |
| 6M | +446.3% | +15.2% | +431.0% | +401.8% |
| YTD | +776.2% | +17.8% | +758.4% | +693.0% |
| 1Y | +987.9% | +55.6% | +932.3% | +799.3% |
| All | +987.9% | +52.5% | +935.5% | +799.3% |
Cumulative growth
Daily Returns
Daily percentage return beside VFC.
Daily Out/Under-Performance
Portfolio return minus VFC return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × VFC return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded VFC wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling